Browse articles from EyeWorld.org related to DSO. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
When treating endothelial dysfunction, surgeons have several options. The current standard of care is endothelial keratoplasty, DSAEK and DMEK. One new therapy that has been getting a lot of attention is corneal endothelial cell therapy, and there has been significant progress in the last 18 months.
Less than 10 years ago, the idea that you could preserve vision and achieve corneal clearance in a patient with Fuchs without donor tissue was met with skepticism. Now this idea is increasingly accepted and adopted. Descemet’s stripping only (DSO), where a descemetorhexis is made in Descemet’s membrane without keratoplasty, was introduced in the mid-2010s.